Citation:Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, et al 2008

Citation

Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008 Apr 20;26(12):2013-9 Available from: http://www.ncbi.nlm.nih.gov/pubmed/18421054.

Critical appraisals

• Assign a critical appraisal

Cited by

1. Role of biological agents in first-line treatment of metastatic colorectal cancer
2. Systemic chemotherapy treatment options for first-line treatment